Nonylphenol-induced hyperadrenalism can be reversed/alleviated by inhibiting of 11-beta hydroxysteroid dehydrogenase type 1

文化大學機構典藏 CCUR > 理工學院 > 工學院 > 化學工程與材料工程學系暨碩士班 > 期刊論文 > Item 987654321/35895

jsp.display-item.identifier=請使用永久網址來引用或連結此文件: https://irlib.pccu.edu.tw/handle/987654321/35895

题名:	Nonylphenol-induced hyperadrenalism can be reversed/alleviated by inhibiting of 11-beta hydroxysteroid dehydrogenase type 1
作者:	Chang, LL (Chang, Ling-Ling) Wun, WSA (Wun, Wan-Song A.) Wang, PS (Wang, Paulus S.)
贡献者:	化材系
关键词:	NP PF915275 Adipogenesis 11 beta-HSD1 Hyperadrenalism Metabolic syndrome
日期:	2016-06
上传时间:	2017-04-13 14:18:12 (UTC+8)
摘要:	We previously observed that nonylphenol (NP) exposure during development resulted in increases in body weight and hyperadrenalism in adult male offspring. The mechanism of hyperadrenalism includes the primary activation of the adrenal gland and the conversion of inactive glucocorticoids to active glucocorticoids by 11 beta-HSD1. The inhibition of 11 beta-HSD1 is investigated as a new therapeutic approach. This study examined the effect of PF915275 (a selective 11 beta-HSD1 inhibitor) on hyperadrenalism and adipogenesis in male rats exposed to NP during development. The results showed that treatment with the 11 beta-HSD1 inhibitor PF915275 reversed/alleviated NP-induced hyperadrenalism via the following mechanisms: (1) decreasing serum corticosterone, 11 beta-hydroxylase, and aldosterone synthase levels; (2) significantly increasing PPAR alpha protein and mRNA expression. In adipose tissue, NP significantly increased PPAR gamma mRNA expression, whereas PF915275 significantly decreased the level of mRNA expression; and (3) the expression of key regulators/enzymes in the adipogenesis metabolic pathway was also modulated. (C) 2016 Elsevier B.V. All rights reserved.
關聯:	ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY 卷: 44 頁碼: 1-12
显示于类别:	[化學工程與材料工程學系暨碩士班] 期刊論文

文件中的档案:

档案	描述	大小	格式	浏览次数
index.html		0Kb	HTML	261	检视/开启

检视Licence

在CCUR中所有的数据项都受到原著作权保护.

数据加载中.....